Zobrazeno 1 - 10
of 151
pro vyhledávání: '"Shane White"'
Autor:
Yee-Ming M Cheung, Rudolf Hoermann, Karen Van, Damian Wu, Jenny Healy, Bella Halim, Manjri Raval, Maria McGill, Ali Al-Fiadh, Michael Chao, Shane White, Belinda Yeo, Jeffrey D Zajac, Mathis Grossmann
Publikováno v:
Endocrine Connections, Vol 12, Iss 10, Pp 1-14 (2023)
Purpose: We previously demonstrated that 12 months of aromatase inhibitor (AI) treatment was not associated with a difference in body compositi on or other markers of cardiometabolic health when compared to controls. Here we report on the pre-planned
Externí odkaz:
https://doaj.org/article/d7c1404461cf45eea291656d8fa7070b
Autor:
Amelia Hyatt, Ruby Lipson-Smith, Karla Gough, Phyllis Butow, Michael Jefford, Thomas F. Hack, Sandra Hale, Emiliano Zucchi, Shane White, Uldis Ozolins, Penelope Schofield
Publikováno v:
Contemporary Clinical Trials Communications, Vol 28, Iss , Pp 100932- (2022)
Background: Oncology patients who are migrants or refugees face worse outcomes due to language and communication barriers impacting care. Interventions such as consultation audio-recordings and question prompt lists may prove beneficial in mediating
Externí odkaz:
https://doaj.org/article/77365d299c614494919d58842f459887
Publikováno v:
Frontiers in Earth Science, Vol 8 (2020)
Changing land use in subtropical and tropical catchments to farmland can result in higher nitrogen (N) loss to aquatic ecosystems. Here, we developed a lumped water and N balance model to estimate regional N losses to creeks at catchment scale within
Externí odkaz:
https://doaj.org/article/fb229eb1060f4b39b2e7b6c88207f8fd
Publikováno v:
Respirology Case Reports, Vol 8, Iss 3, Pp n/a-n/a (2020)
Abstract Immune checkpoint inhibitors (ICIs) have become pivotal in the treatment of lung cancer. An increasing number of immune‐related adverse events (irAEs) have been recognized with their use. To our knowledge, this is the first published case
Externí odkaz:
https://doaj.org/article/bd66b99b10c44385ac8cf47c29e711f1
Publikováno v:
Journal of Ophthalmic & Vision Research, Vol 9, Iss 3, Pp 324-328 (2014)
Purpose: To assess the refractive and visual outcomes following cataract surgery and implantation of the AcrySof IQ Toric SN6AT2 intraolcular lens (IOL) (Alcon Laboratories, Inc., Fort Worth, TX, USA) in patients with low corneal astigmatism. Methods
Externí odkaz:
https://doaj.org/article/d8c875bbcd5e4307ad976de93329b986
Autor:
Shane White, Graham White
For over two centuries, in the North as well as the South, both within their own community and in the public arena, African Americans have presented their bodies in culturally distinctive ways. Shane White and Graham White consider the deeper signifi
The phrase “Harlem in the 1920s” evokes images of the Harlem Renaissance, or of Marcus Garvey and soapbox orators haranguing crowds about politics and race. Yet the most ubiquitous feature of Harlem life between the world wars was the game of “
Autor:
Yee‐Ming M. Cheung, Rudolf Hoermann, Karen Van, Damian Wu, Jenny Healy, Michael Chao, Shane White, Belinda Yeo, Jeffrey Zajac, Mathis Grossmann
Publikováno v:
Clinical endocrinologyREFERENCES.
Aromatase inhibitor (AI) therapy provides oncological benefits in postmenopausal women with oestrogen receptor-positive breast cancer. However, AI treatment has been associated with increased cardiovascular risk. In nonbreast cancer populations, expe
Autor:
Shane White
Stories of Freedom in Black New York recreates the experience of black New Yorkers as they moved from slavery to freedom. In the early decades of the nineteenth century, New York City's black community strove to realize what freedom meant, to find a
Autor:
Steven David, Peter Savas, Shankar Siva, Michelle White, Michael W Neeson, Shane White, Gavin Marx, Robyn Cheuk, Michelle Grogan, Maria Farrell, Jessica Foudoulis, Annette Dempsey, Paul J Neeson, Mathias Bressel, Sherene Loi
Publikováno v:
Cancer Research. 82:PD10-02
A randomised phase II trial of single fraction or multi-fraction SABR (stereotactic ablative body radiotherapy) with atezolizumab in patients with advanced triple negative breast cancer (AZTEC trial) Abstract: BACKGROUND: In patients with advanced tr